excluded from ENGAGE AF-TIMI 48.
Page 1171, Table 1: Weight #50 kg should have read Weight #60 kg Second sentence in table legend should have read: *In ENGAGE AF-TIMI 48, the dose of edoxaban was halved in patients with body weight #60 kg, a calculated creatinine clearance of 30 to 50 ml/min using the CockcroftGault equation, or who required concomitant use of verapamil, quinidine, or dronedarone.
Page 1171, right column, first paragraph (below Table 1 ):
Adjusted HRs (adj HRs) and 95% CI comparing the relative efficacy and safety of edoxaban versus warfarin were calculated with the addition of adjustment for differences in baseline characteristics across randomized treatment groups in patients at increased risk of falling (Table 2 : diastolic blood pressure, diabetes, and weight).
should have read:
Adjusted HRs (adj HRs) and 95% CI comparing the relative efficacy and safety of edoxaban versus warfarin were calculated with the addition of adjustment for differences in baseline characteristics across randomized treatment groups in patients at increased risk of falling (Online Table 1 : diastolic blood pressure, diabetes, and weight).
Page 1172, right column, first paragraph:
Patient characteristics were similar among the 3 treatment groups, except for lower diastolic pressure and higher prevalence of patients with weight <50 kg in the warfarin arm, and higher prevalence of diabetes in the HDER arm.
Patient characteristics were similar among the 3 treatment groups, except for lower diastolic pressure and higher prevalence of patients with weight #50 kg in the warfarin arm, and higher prevalence of diabetes in the HDER arm.
Page 1175, first line:
(ARR, À106 events/10,000 patient-years [95% CI: À230 to þ18] vs. À31 events/10,000 patient-years [95% CI: À47 to À15) should have read:
(ARR, À141 events/10,000 patient-years [95% CI: À272 to À10] vs. À33 events/10,000 patient-years
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Central Illustration: The orange bar under Life-threatening bleeding should have read À141, NNT¼71 and the blue bar should have read: À33, NNT¼302. The revised Central illustration is printed below.
The authors apologize for these errors.
The online version of the article has been corrected to reflect these changes. The following sentence read: "Moreover, a recent retrospective analysis from the VA of 509,766 eligible adults with ASCVD at baseline showed over 1 year a graded association between intensity of statin therapy and mortality (8).", but should have read "Moreover, a recent retrospective analysis from the VA of 509,766 eligible adults with ASCVD at baseline showed over 1 year a graded association between intensity of statin therapy and mortality (9)."
The following reference (9) has been added and all references have been subsequently renumbered. The author apologizes for this error.
The online version of the article has been corrected to reflect this change. 
